TELA Bio, Inc. announced the appointment of Greg Firestone as the company?s new chief commercial officer. In this role, Mr. Firestone will oversee the company?s commercial operations, including key product launches, sales team training, market development, as well as strategic initiatives to optimize market access and reimbursement strategy across the company?s product lines. Mr. Firestone has been a member of TELA?s executive leadership since October 2017, most recently serving as the Company?s Chief Business Officer, where he led the strategic customer relations team.

He brings over 35 years of experience in the acute and non-acute healthcare sectors, with much of his tenure in strategy and partnership development, stakeholder collaboration, and strategic consulting initiatives. Throughout his career, Mr. Firestone has worked closely with IDNs, health systems, GPOs, and suppliers, developing deep relationships throughout the MedTech landscape. Prior to his tenure at TELA Bio, he held several executive and sales leadership roles in medical device, GPO and logistics, including as founder and CEO of Dermal Life, LLC, co-founder and president of Mossberg Labs, and owner and CEO of NCI, where Mr. Firestone founded the IDN Summit & Expo, and authored Swimming with the Supertankers, a book written to assist supplier sales and marketing professionals.